GB0723100D0 - Treatment of HFnEF - Google Patents

Treatment of HFnEF

Info

Publication number
GB0723100D0
GB0723100D0 GBGB0723100.4A GB0723100A GB0723100D0 GB 0723100 D0 GB0723100 D0 GB 0723100D0 GB 0723100 A GB0723100 A GB 0723100A GB 0723100 D0 GB0723100 D0 GB 0723100D0
Authority
GB
United Kingdom
Prior art keywords
hfnef
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0723100.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heart Metabolics Ltd
Original Assignee
Heart Metabolics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heart Metabolics Ltd filed Critical Heart Metabolics Ltd
Priority to GBGB0723100.4A priority Critical patent/GB0723100D0/en
Publication of GB0723100D0 publication Critical patent/GB0723100D0/en
Priority to PCT/GB2008/003913 priority patent/WO2009066085A1/en
Priority to US12/785,077 priority patent/US8440697B2/en
Priority to US13/838,458 priority patent/US9457017B2/en
Priority to US13/839,313 priority patent/US9468634B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
GBGB0723100.4A 2007-11-23 2007-11-23 Treatment of HFnEF Ceased GB0723100D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0723100.4A GB0723100D0 (en) 2007-11-23 2007-11-23 Treatment of HFnEF
PCT/GB2008/003913 WO2009066085A1 (en) 2007-11-23 2008-11-24 Treatment of heart failure with normal ejection fraction
US12/785,077 US8440697B2 (en) 2007-11-23 2010-05-21 Treatment of heart failure
US13/838,458 US9457017B2 (en) 2007-11-23 2013-03-15 Treatment of heart failure
US13/839,313 US9468634B2 (en) 2007-11-23 2013-03-15 Treatment of heart failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0723100.4A GB0723100D0 (en) 2007-11-23 2007-11-23 Treatment of HFnEF

Publications (1)

Publication Number Publication Date
GB0723100D0 true GB0723100D0 (en) 2008-01-02

Family

ID=38926031

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0723100.4A Ceased GB0723100D0 (en) 2007-11-23 2007-11-23 Treatment of HFnEF

Country Status (2)

Country Link
GB (1) GB0723100D0 (en)
WO (1) WO2009066085A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405381D0 (en) 2004-03-10 2004-04-21 Univ Wales Medicine A method and means for treating heart failure
WO2010133815A1 (en) 2009-05-20 2010-11-25 Heart Metabolics Limited Treatment of heart failure with normal ejection fraction
GB0908193D0 (en) 2009-05-13 2009-06-24 Albright Patents Treatment of disease state
AU2013313021A1 (en) * 2012-09-05 2015-03-26 Adelaide Research & Innovation Pty Ltd Uses of (-)-perhexiline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405381D0 (en) * 2004-03-10 2004-04-21 Univ Wales Medicine A method and means for treating heart failure

Also Published As

Publication number Publication date
WO2009066085A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
HK1207578A1 (en) Treatment of synucleinopathies
GB2454797B (en) Treatment of wastewater
IL208354A0 (en) Methods of treatment
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
GB0822011D0 (en) Treatment
GB0711342D0 (en) Well treatment
HRP20130395T1 (en) Treatment of melanoma
GB0811992D0 (en) Treatment
ZA201000225B (en) Treatment of depression
EP2184353A4 (en) Treatment of influenza
HK1145634A1 (en) Treatment of atherosclerosis
GB0708452D0 (en) Treatment of nuclear studge
GB0716784D0 (en) Well treatment
GB0723100D0 (en) Treatment of HFnEF
EP2164494A4 (en) Methods of treatment
GB0820972D0 (en) Treatment
EP2142256A4 (en) Treatment of obesity
GB0805912D0 (en) Treatment
EP2203432A4 (en) Method of treatment
GB0700969D0 (en) Methods of treatment
GB0625602D0 (en) Treatment of sialorrhoea
GB0809319D0 (en) The treatment of puritus
GB0724838D0 (en) Effulent treatment
GB0710732D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)